SLAB Spacelabs Regs

Spacelabs Healthcare Inc.
07 March 2007


Spacelabs Healthcare Announces FDA Clearance for U.S. Sale and Distribution of
Diagnostic Cardiology Data Management System

HAWTHORNE, CA -- (MARKET WIRE) -- March 07, 2007 -- Spacelabs Healthcare, Inc.
(LSE: SLAB), an international medical equipment company listed on the London AIM
market, announced today that it has received 510(k) clearance from the U.S. Food
and Drug Administration ("FDA") to distribute in the U.S. its new Cardiology
Data Management system, Sentinel.

Sentinel integrates the entire range of non-invasive diagnostic cardiology
solutions including: ECG Exercise Testing, 12-Lead ECG, Holter Monitoring, ECG
Event Recording and Ambulatory Blood Pressure Monitoring into one central data
management system. The system enables a straightforward approach to
consolidation and management of diagnostic cardiology procedures by centralizing
all solutions in a central networked database that reduces the need for paper
records, increases time saved in searching for patient details and improves
workflow management.

The system has been designed for use either in a single station, such as within
a physician's office, or as a fully scalable solution for large multi-centered
hospitals. It is fully networkable and compatible with existing systems and
third party vendor applications. Sentinel is also designed to integrate with
existing hospital information systems allowing seamless connectivity of patient
records from admission through recording, diagnosis and discharge. Patient
reports can be viewed at workstations or via the web from any location through
secured security software.

Deepak Chopra, Chief Executive Officer Spacelabs Healthcare, stated, "We are
excited about achieving 510(k) clearance for Sentinel, our new Cardiology Data
Management system. We believe that Sentinel provides physicians with an
uncompromised facility to perform and to track the full range of diagnostic
cardiology procedures from both internal and third party vendors' applications."

The FDA requires that all medical devices introduced to the U.S. be preceded
either by a pre-market notification clearance order under section 510(k) of the
Food, Drug and Cosmetic Act, or an approved pre-market approval application. A
510(k) pre-market notification clearance order indicates that the FDA agrees
with an applicant's determination that the product for which clearance has been
sought is substantially equivalent to another legally marketed medical device.

About Spacelabs Healthcare

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international
developer, manufacturer and distributor of medical equipment and services
including patient monitoring solutions, anesthesia delivery and ventilation
systems, diagnostic cardiology solutions and supplies and accessories selling to
hospitals, clinics and physicians offices. Additionally, the Company provides
ECG laboratory services to pharmaceutical companies undertaking clinical trials,
whereby patient ECG data is recorded, analyzed, tabulated and interpreted.

The Company employs approximately 1,250 personnel in offices located in the UK,
Canada, India, France, Germany, Finland, Singapore and the United States.

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements include information
regarding our expectations, goals or intentions about the future, including, but
not limited to, statements regarding the market acceptance of the Sentinel
Cardiology Data Management System. The actual results may differ materially from
those described in or implied by any forward-looking statement. Other important
factors are set forth in our Securities and Exchange Commission filings. All
forward-looking statements speak only as of the date made, and we undertake no
obligation to update these forward-looking statements.

For Further Information

Investor Contact
Jeremy Norton
Jnorton@osi-systems.com
310-717-9182

Media Contact
Dan Prueher
dan.prueher@spacelabs.com
608-695-5957




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
NRAEAADXEEDXEFE

Spacelabs Healthcare (LSE:SLAB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Spacelabs Healthcare (LSE:SLAB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024